FI101849B1 - Antimikrobiset koostumukset ja niiden käyttö silmälääkkeiden säilömiseksi ja piilolinssien hoitamiseksi - Google Patents

Antimikrobiset koostumukset ja niiden käyttö silmälääkkeiden säilömiseksi ja piilolinssien hoitamiseksi

Info

Publication number
FI101849B1
FI101849B1 FI904616A FI904616A FI101849B1 FI 101849 B1 FI101849 B1 FI 101849B1 FI 904616 A FI904616 A FI 904616A FI 904616 A FI904616 A FI 904616A FI 101849 B1 FI101849 B1 FI 101849B1
Authority
FI
Finland
Prior art keywords
contact lenses
antimicrobial compositions
ophthalmic drugs
treating contact
preserving ophthalmic
Prior art date
Application number
FI904616A
Other languages
English (en)
Swedish (sv)
Other versions
FI101849B (fi
FI904616A0 (fi
Inventor
Gyoergy Lajos Kis
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of FI904616A0 publication Critical patent/FI904616A0/fi
Application granted granted Critical
Publication of FI101849B publication Critical patent/FI101849B/fi
Publication of FI101849B1 publication Critical patent/FI101849B1/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12
    • A61L12/143—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Eyeglasses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI904616A 1989-09-21 1990-09-19 Antimikrobiset koostumukset ja niiden käyttö silmälääkkeiden säilömiseksi ja piilolinssien hoitamiseksi FI101849B1 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH344689 1989-09-21
CH344689 1989-09-21

Publications (3)

Publication Number Publication Date
FI904616A0 FI904616A0 (fi) 1990-09-19
FI101849B FI101849B (fi) 1998-09-15
FI101849B1 true FI101849B1 (fi) 1998-09-15

Family

ID=4256126

Family Applications (1)

Application Number Title Priority Date Filing Date
FI904616A FI101849B1 (fi) 1989-09-21 1990-09-19 Antimikrobiset koostumukset ja niiden käyttö silmälääkkeiden säilömiseksi ja piilolinssien hoitamiseksi

Country Status (18)

Country Link
EP (1) EP0420798B1 (fi)
JP (1) JP2960507B2 (fi)
AT (1) ATE103182T1 (fi)
AU (1) AU640687B2 (fi)
CA (1) CA2025728C (fi)
DD (1) DD299267A5 (fi)
DE (1) DE59005084D1 (fi)
DK (1) DK0420798T3 (fi)
ES (1) ES2053161T3 (fi)
FI (1) FI101849B1 (fi)
HU (2) HUT59001A (fi)
IE (1) IE71639B1 (fi)
IL (1) IL95720A (fi)
NO (1) NO179472C (fi)
NZ (1) NZ235377A (fi)
PH (1) PH29982A (fi)
PT (1) PT95355B (fi)
ZA (1) ZA907536B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5037647A (en) * 1988-09-15 1991-08-06 Alcon Laboratories, Inc. Aqueous antimicrobial opthalmic solutions comprised of quaternary ammonium compound, citric acid, citrate and sodium chloride
AU6859394A (en) * 1993-05-25 1994-12-20 Auckland Uniservices Limited Nitrobenzyl mustard quaternary salts and their use as hypoxia-selective cytotoxic agents
JP4849288B2 (ja) * 2000-09-29 2012-01-11 ライオン株式会社 点眼剤及び涙液膜の安定化剤
JP2010031052A (ja) * 2002-04-08 2010-02-12 Lion Corp 眼科用組成物、及び眼科製剤用防腐組成物
US20050214382A1 (en) * 2004-03-29 2005-09-29 Erning Xia Zinc preservative composition and method of use
DE202005005094U1 (de) * 2005-03-31 2005-07-28 Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh Ophthalmische Zusammensetzung
AU2009319167A1 (en) * 2008-11-28 2010-06-03 Lectio Pharmaentwicklungs-Und Verwertungs Gmbh Pharmaceutical formulation comprising diclofenac and a hydroxy fatty acid polyoxyalkylene ester
JP2012006962A (ja) * 2011-08-22 2012-01-12 Lion Corp 眼科用組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR204836A1 (es) * 1973-09-24 1976-03-05 Allergan Pharma Composicion para esterilizar lentes de contacto blandos
DE3612537C1 (de) * 1986-04-14 1987-07-16 Dispersa Ag Arzneimittel zur Behandlung von Entzuendungen im Auge
IL87724A (en) * 1987-09-11 1992-01-15 Syntex Inc Ophthalmic compositions,their preparation and use

Also Published As

Publication number Publication date
NO904112L (no) 1991-03-22
ATE103182T1 (de) 1994-04-15
NO179472B (no) 1996-07-08
ES2053161T3 (es) 1994-07-16
EP0420798A1 (de) 1991-04-03
IL95720A0 (en) 1991-06-30
NO179472C (no) 1996-10-16
EP0420798B1 (de) 1994-03-23
HU210525A9 (en) 1995-04-28
HUT59001A (en) 1992-04-28
IE71639B1 (en) 1997-02-26
PT95355B (pt) 1997-06-30
AU640687B2 (en) 1993-09-02
IE903406A1 (en) 1991-04-10
FI101849B (fi) 1998-09-15
PH29982A (en) 1996-10-29
IL95720A (en) 1996-07-23
NO904112D0 (no) 1990-09-20
FI904616A0 (fi) 1990-09-19
DK0420798T3 (da) 1994-04-11
CA2025728C (en) 2002-02-26
ZA907536B (en) 1991-05-29
DD299267A5 (de) 1992-04-09
CA2025728A1 (en) 1991-03-22
AU6302490A (en) 1991-03-28
HU905995D0 (en) 1991-03-28
JP2960507B2 (ja) 1999-10-06
JPH03130219A (ja) 1991-06-04
PT95355A (pt) 1991-05-22
DE59005084D1 (de) 1994-04-28
NZ235377A (en) 1992-08-26

Similar Documents

Publication Publication Date Title
ATE232862T1 (de) Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen
PT1235826E (pt) Acrilamidas de quinuclidina
ATE211384T1 (de) Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera
NO902800L (no) Fremgangsmaate for fremstilling av 11beta-aryl-4-oestrener.
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
FI101849B1 (fi) Antimikrobiset koostumukset ja niiden käyttö silmälääkkeiden säilömiseksi ja piilolinssien hoitamiseksi
DE69218816D1 (de) N-acetyl-cysteine Derivate enthaltende pharmazeutische Zusammensetzung zur Behandlung von Katarakt
ATE5256T1 (de) Phenylpiperazinderivate von 1,3,4oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel.
HUP0000110A2 (hu) Azaciklusos, azabiciklusos vagy tetrahidropiridinszármazékokat tartalmazó, fájdalom kezelésére alkalmas gyógyászati készítmények
FI923662A0 (fi) Terapeutiska medel.
DE59101818D1 (de) Arzneimittelzubereitung, enthaltend Stigmasta-4-en-3-on sowie deren Verwendung.
NO913685L (no) Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer.
DE69117974D1 (de) Pharmazeutische zusammensetzungen zur behandlung von b-zell-entartungen
DE69800906T2 (de) Verwendung von Olanzapine zur Herstellung eines Arzneimittels zur Behandlung der zerebralen fokalen Ischämie

Legal Events

Date Code Title Description
FG Patent granted

Owner name: NOVARTIS AG

HC Name/ company changed in application

Owner name: NOVARTIS AG

GB Transfer or assigment of application

Owner name: NOVARTIS AG

GB Transfer or assigment of application

Owner name: NOVARTIS AG

FG Patent granted

Owner name: NOVARTIS AG

MA Patent expired